(part of the ACCP/ASHP Oncology Pharmacy Webinar Series)
ACCP collaborates with ASHP on Oncology Pharmacy activities.
ASHP members, please visit www.rxcertifications.org to receive member pricing.
Target Audience
The target audience for this webinar is the pharmacist interested in learning more about updated information regarding oncologic management and/or treatment, and for Board-certified Oncology Pharmacists (BCOPs) looking to earn recertification credit.
Overview
This webinar series is part of the professional development program for the recertification of the BCOP pharmacist.
This course is intended for BCOPs in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS) to provide an overview of recent standards and guidelines that specialists should be familiar with in practice.
This online activity is approved for 1.5 hours of continuing pharmacy education credit and/or recertification credit.
This webinar recording covers use of oral hypomethylating agents in case-based examples, decitabine/cedazuridine use for MDS, oral azacitidine use in AML patients, dosing and administration for those agents, and related ongoing or upcoming clinical trials.
Pre-Sale Date: April 13, 2022
Release date: May 18, 2022
BCOP credit expiration date: May 9, 2023
ACPE credit expiration date: May 9, 2025
Faculty
| |
| A Review of Oral Hypomethylating Agents in MDS and AML |
| |
 |
Danielle Schlafer, Pharm.D., BCOP
Clinical Pharmacy Specialist, Leukemia
Emory Healthcare/Winship Cancer Institute
Atlanta, Georgia |
Reviewers
- Melanie Brooke Bernhardt, Pharm.D., M.S., BCOP, BCPPS
- Christopher T. Elder, Pharm.D., BCOP
Conflicts of Interest 
Learning Objectives
Learning Objectives
Continuing Pharmacy Education Credit
The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
The ACCP/ASHP BCOP Webinar Series: A Review of Oral Hypomethylating Agents in MDS and AML 2022 Webinar Recording will provide one session with 1.5 contact hours of continuing pharmacy education credit and/or 1.5 hours of BCOP recertification credit. The Universal Activity Number for this webinar is:
Activity Number: 0217-9999-22-032-H01-P
1.5 contact hours
Application-based activity
To be eligible to earn ACPE continuing pharmacy education (CPE) credit, participants must purchase the ACCP/ASHP BCOP Webinar Series: A Review of Oral Hypomethylating Agents in MDS and AML 2022 Webinar Recording, and successfully review all content and complete, submit and pass the Web-based posttest by May 9, 2025. Posttests may not be submitted more than one time. Partial credit is not available for this activity.
National Association of Boards of Pharmacy - CPE Monitor Service
Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.
To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.
Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.
Recertification Credit
To be eligible to earn BCOP recertification credit, participants must purchase the ACCP/ASHP BCOP Webinar Series: A Review of Oral Hypomethylating Agents in MDS and AML 2022 Webinar Recording, successfully review the recordings, and complete, submit and pass the Web-based posttest by May 9, 2023. The passing point to earn BCOP recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the BCOP posttest deadline that meets this passing point will earn BCOP recertification credits. These credits will be assigned as of the date of test submission. Posttests may not be submitted more than one time. Partial credit is not available for this activity. For statements of recertification credit, visit www.bpsweb.org.
All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.
Questions regarding the number of hours required for BCOP recertification should be directed to BPS at (202) 946-5026 or www.bpsweb.org.
Hardware and Software Requirements
To access the webinar recording by a computer, you will need broadband Internet access, an updated Internet browser, Adobe Flash Player, and speakers or headphones for audio.
To access the webinars on a Wi-Fi enabled mobile device, you will need a wireless internet connection and the Adobe Connect App, a free app which can be downloaded from Apple’s App Store or Google Play.
Participants who experience difficulty in accessing a webinar should contact ACCP by e-mail at [email protected] or by phone at (913) 492-3311.
Commercial Support
The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.